help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanoh, Y.
Right arrow Articles by Farese, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanoh, Y.
Right arrow Articles by Farese, R. V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Endocrinology Vol. 144, No. 3 947-954
Copyright © 2003 by The Endocrine Society

ARTICLE

Defective Activation of Atypical Protein Kinase C {zeta} and {lambda} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 in Skeletal Muscle of Rats Following High-Fat Feeding and Streptozotocin-Induced Diabetes

Yoshinori Kanoh, Mini P. Sajan, Gautam Bandyopadhyay, Atsushi Miura, Mary L. Standaert and Robert V. Farese

Research Service, James A. Haley Veterans Administration Medical Center and Department of Internal Medicine, University of South Florida College of Medicine, Tampa, Florida 33612

Address all correspondence and requests for reprints to: Robert V. Farese, M.D., ACOS-151, James A. Haley Veterans Administration Hospital, 13000 Bruce B. Downs Boulevard, Tampa, Florida 33612. E-mail: rfarese{at}hsc.med.usf.edu.

Insulin-stimulated glucose transport in skeletal muscle is thought to be effected at least partly through atypical protein kinase C isoforms (aPKCs) operating downstream of phosphatidylinositol (PI) 3-kinase and 3-phosphoinositide-dependent protein kinase-1 (PDK-1). However, relatively little is known about the activation of aPKCs in physiological conditions or insulin-resistant states. Presently, we studied aPKC activation in vastus lateralis muscles of normal chow-fed and high-fat-fed rats and after streptozotocin (STZ)-induced diabetes. In normal chow-fed rats, dose-dependent increases in aPKC activity approached maximal levels after 15–30 min of stimulation by relatively high and lower, presumably more physiological, insulin concentrations, achieved by im insulin or ip glucose administration. Insulin-induced activation of aPKCs was impaired in both high-fat-fed and STZ-diabetic rats, but, surprisingly, IRS-1-dependent and IRS-2-dependent PI 3-kinase activation was not appreciably compromised. Most interestingly, direct in vitro activation of aPKCs by PI-3,4,5-(PO4)3, the lipid product of PI 3-kinase, was impaired in both high-fat-fed and STZ-diabetic rats. Defects in activation of aPKCs by insulin and PI-3,4,5-(PO4)3 could not be explained by diminished PDK-1-dependent phosphorylation of threonine-410 in the PKC-{zeta} activation loop, as this phosphorylation was increased even in the absence of insulin treatment in high-fat-fed rats. Conclusions: 1) muscle aPKCs are activated at relatively low, presumably physiological, as well as higher supraphysiological, insulin concentrations; 2) aPKC activation is defective in muscles of high-fat-fed and STZ-diabetic rats; and 3) defective aPKC activation in these states is at least partly due to impaired responsiveness to PI-3,4,5-(PO4)3, apparently at activation steps distal to PDK-1-dependent loop phosphorylation.




This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
M. P. Sajan, M. L. Standaert, S. Nimal, U. Varanasi, T. Pastoor, S. Mastorides, U. Braun, M. Leitges, and R. V. Farese
The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NF{kappa}B in obesity
J. Lipid Res., June 1, 2009; 50(6): 1133 - 1145.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. C. Levin, M. Monetti, M. J. Watt, M. P. Sajan, R. D. Stevens, J. R. Bain, C. B. Newgard, R. V. Farese Sr., and R. V. Farese Jr.
Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1772 - E1781.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. B. Yaspelkis III, S. J. Lessard, D. W. Reeder, J. J. Limon, M. Saito, D. A. Rivas, I. Kvasha, and J. A. Hawley
Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E941 - E949.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Frosig, A. J. Rose, J. T. Treebak, B. Kiens, E. A. Richter, and J. F.P. Wojtaszewski
Effects of Endurance Exercise Training on Insulin Signaling in Human Skeletal Muscle: Interactions at the Level of Phosphatidylinositol 3-Kinase, Akt, and AS160
Diabetes, August 1, 2007; 56(8): 2093 - 2102.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
C. Frosig, M. P. Sajan, S. J. Maarbjerg, N. Brandt, C. Roepstorff, J. F. P. Wojtaszewski, B. Kiens, R. V. Farese, and E. A. Richter
Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle
J. Physiol., August 1, 2007; 582(3): 1289 - 1301.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. P Corcoran, S. Lamon-Fava, and R. A Fielding
Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 662 - 677.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
V. Wong, L. Szeto, K. Uffelman, I G. Fantus, and G. F Lewis
Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway.
J. Endocrinol., August 1, 2006; 190(2): 441 - 450.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Frangioudakis, J.-M. Ye, and G. J. Cooney
Both Saturated and n-6 Polyunsaturated Fat Diets Reduce Phosphorylation of Insulin Receptor Substrate-1 and Protein Kinase B in Muscle during the Initial Stages of in Vivo Insulin Stimulation
Endocrinology, December 1, 2005; 146(12): 5596 - 5603.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
R. V. Farese, M. P. Sajan, and M. L. Standaert
Insulin-Sensitive Protein Kinases (Atypical Protein Kinase C and Protein Kinase B/Akt): Actions and Defects in Obesity and Type II Diabetes
Experimental Biology and Medicine, October 1, 2005; 230(9): 593 - 605.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
H. J. Herr, J. R. Bernard, D. W. Reeder, D. A. Rivas, J. J. Limon, and B. B. Yaspelkis III
Insulin-stimulated plasma membrane association and activation of Akt2, aPKC {zeta} and aPKC {lambda} in high fat fed rodent skeletal muscle
J. Physiol., June 1, 2005; 565(2): 627 - 636.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. P. Sajan, M. L. Standaert, A. Miura, C. R. Kahn, and R. V. Farese
Tissue-Specific Differences in Activation of Atypical Protein Kinase C and Protein Kinase B in Muscle, Liver, and Adipocytes of Insulin Receptor Substrate-1 Knockout Mice
Mol. Endocrinol., October 1, 2004; 18(10): 2513 - 2521.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. P. Sajan, M. L. Standaert, A. Miura, G. Bandyopadhyay, P. Vollenweider, D. M. Franklin, R. Lea-Currie, and R. V. Farese
Impaired Activation of Protein Kinase C-{zeta} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 in Cultured Preadipocyte-Derived Adipocytes and Myotubes of Obese Subjects
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3994 - 3998.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Zabolotny, F. G. Haj, Y.-B. Kim, H.-J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, and B. B. Kahn
Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action
J. Biol. Chem., June 4, 2004; 279(23): 24844 - 24851.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. D. Krisan, D. E. Collins, A. M. Crain, C. C. Kwong, M. K. Singh, J. R. Bernard, and B. B. Yaspelkis III
Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle
J Appl Physiol, May 1, 2004; 96(5): 1691 - 1700.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
P. Weyrich, K. Kapp, G. Niederfellner, M. Melzer, R. Lehmann, H.-U. Haring, and R. Lammers
Partitioning-Defective Protein 6 Regulates Insulin-Dependent Glycogen Synthesis via Atypical Protein Kinase C
Mol. Endocrinol., May 1, 2004; 18(5): 1287 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. D. Fluckey, R. N. Cortright, E. Tapscott, T. Koves, L. Smith, S. Pohnert, and G. L. Dohm
Active involvement of PKC for insulin-mediated rates of muscle protein synthesis in Zucker rats
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E753 - E758.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Beeson, M. P. Sajan, M. Dizon, D. Grebenev, J. Gomez-Daspet, A. Miura, Y. Kanoh, J. Powe, G. Bandyopadhyay, M. L. Standaert, et al.
Activation of Protein Kinase C-{zeta} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 Is Defective in Muscle in Type 2 Diabetes and Impaired Glucose Tolerance: Amelioration by Rosiglitazone and Exercise
Diabetes, August 1, 2003; 52(8): 1926 - 1934.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society